Our Leadership Team

Talat Ashraf

MD, MS, Vice President, Clinical Safety and Risk Management

Talat Ashraf graduated in medicine from the University of Health Sciences, Pakistan (Quaid-e-Azam Medical College) and completed residency in internal medicine at Abbasi Shaheed Hospital, Karachi Medical and Dental College. Dr. Ashraf served as an instructor and faculty at the Department of Community Health Sciences, Aga Khan University, Pakistan.  As part of work at the Aga Khan University, Dr. Ashraf taught medical students, provided clinical services, and worked on health care access for urban squatter settlement and has done extensive work in evaluating public health care programs. Dr. Ashraf also has Master of Science from the University of Cincinnati, Ohio, United States in health planning and administration and graduated with outstanding master student award. Dr. Ashraf, currently serve as an adjunct Professor to the Department of Pharmaceutics and Medicinal Chemistry, Thomas J. Long School of Pharmacy, University of the Pacific, California, United States, with focus on drug development. Dr. Ashraf is an external peer reviewer for National Institute for Health Research, funded by Department of Health and Social Care, United Kingdom. Over the past 20 years Dr. Ashraf has worked for companies such as Abbott, Johnson and Johnson, Medtronic, and Vertex pharmaceuticals in the areas of clinical research, drug development, Drug Safety-Pharmacovigilance and Risk Assessment, health economics, and access to health care. Dr. Ashraf has  numerous patents in analytical techniques to evaluate health effect in psoriasis, Crohn’s disease, and prostate cancer. Dr Ashraf  is published in medical journals such as Lancet Oncology, The America  Journal of Cardiology, Journal of the American College of Cardiology, Value in Health, Pharmacoeconomics, American Journal of Neuroradiology, American Society of Hematology – Blood, North American Spine Society – The Spine Journal, Quality of Life Research, American Journal of Reproductive Medicine, Drug Benefit Trend, and America Heart Association Journal.